Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Adipose-derived stromal vascular fraction aids epithelialisation and angiogenesis in an animal model..
J Wound Care. 27(10), 637-644.
(2018). Adipose tissue, obesity and non-alcoholic fatty liver disease..
Minerva Endocrinol. 42(2), 92-108.
(2017). Adiponectin levels reflect the different phenotypes of polycystic ovary syndrome: study in normal weight, normoinsulinemic patients..
Fertil Steril. 92(6), 2078-81.
(2009). Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis..
Hum Reprod Update. 15(3), 297-307.
(2009). Adiponectin in non-alcoholic fatty liver disease treatment: therapeutic perspectives and unresolved dilemmas..
Int J Clin Pract. 65(3), 373-4.
(2011). Adiponectin gene polymorphisms in obese Greek youth..
J Pediatr Endocrinol Metab. 22(10), 955-9.
(2009). Adiponectin as a target for the treatment of nonalcoholic steatohepatitis with thiazolidinediones: A systematic review..
Metabolism. 65(9), 1297-306.
(2016). Adiponectin as a potential therapeutic agent for nonalcoholic steatohepatitis..
Hepatol Res. 40(4), 446-7.
(2010). Adiponectin and vitamin D-binding protein concentrations are independently associated in apparently healthy women but not men: a validation cohort..
Hormones (Athens). 18(1), 99-102.
(2019). Adiponectin and vitamin D-binding protein are independently associated at birth in both mothers and neonates..
Endocrine. 59(1), 164-174.
(2018). Adiponectin and insulin resistance in childhood obesity..
J Pediatr Gastroenterol Nutr. 47(3), 356-62.
(2008). Adiponectin and body composition in cystic fibrosis..
J Cyst Fibros. 7(3), 244-51.
(2008).
(2014). Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss..
Obes Facts. 5(4), 495-504.
(2012). The adipokines in the pathogenesis and treatment of nonalcoholic fatty liver disease..
Hippokratia. 20(4), 259-263.
(2016). Adipokines in nonalcoholic fatty liver disease..
Metabolism. 65(8), 1062-79.
(2016). Adipokines and vascular risk in type 2 diabetes mellitus..
Angiology. 62(8), 601-4.
(2011). Adipokines and stroke: a review of the literature..
Maturitas. 70(4), 322-7.
(2011). Adipokines: a novel link between adiposity and carotid plaque vulnerability..
Eur J Clin Invest. 42(12), 1278-86.
(2012). Adipocytokines levels at delivery, functional variation of TFAP2β, and maternal and neonatal anthropometric parameters..
Obesity (Silver Spring). 21(10), 2130-7.
(2013). Adipocytokines in relation to Hodgkin lymphoma in children..
Pediatr Blood Cancer. 54(2), 311-5.
(2010). Adipocytokines in insulin resistance and non-alcoholic fatty liver disease: the two sides of the same coin..
Med Hypotheses. 74(6), 1089-90.
(2010). Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease: Introduction of CHA index..
Ann Hepatol. 12(5), 749-57.
(2013).
(2017).
(2013).